Mesoblast Limited MESO
Set alert
14.79 USD +0.25 +1.69%
As of Nov 3, 3:14 PM ET
14.79 Day range 15.15
11.89 52-week range 21.50
- YTD
- -18.04%
- 1 year
- -8.22%
- Open
- 14.92
- Prev close
- 14.54
- Mkt cap
- 1.92B
- Vol
- 97.27K
- Avg vol
- 235.65K
- EPS
- -0.44
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 14.79
- High
- 15.15
- Forward P/E
- 31.96
- Beta
- 0.91
- Short ratio
- 14.11
- Inst. own
- 3.27%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Mar 4, 2027
- 50-d avg
- 14.93
- 200-d avg
- 15.41
- 1y target
- 37.00
5m chart
Built from the cached five-day intraday bars.
Signals (105)
| Name | Time | Ago |
|---|---|---|
| MACD: Buy Signal | Nov 2, 2:55 PM | 1 day ago |
| SMA: Bullish | Nov 2, 2:50 PM | 1 day ago |
| MACD: Sell Signal | Nov 2, 2:35 PM | 1 day ago |
| SMA: Bullish | Nov 2, 2:10 PM | 1 day ago |
| SMA: Bearish | Nov 2, 2:00 PM | 1 day ago |
| SMA: Bullish | Nov 2, 1:50 PM | 1 day ago |
| MACD: Buy Signal | Nov 2, 1:50 PM | 1 day ago |
| SMA: Bearish | Nov 2, 1:40 PM | 1 day ago |
| MACD: Sell Signal | Nov 2, 1:40 PM | 1 day ago |
| MACD: Buy Signal | Nov 2, 1:35 PM | 1 day ago |
| SMA: Bullish | Nov 2, 1:20 PM | 1 day ago |
| MACD: Sell Signal | Nov 2, 12:45 PM | 1 day ago |
| MACD: Buy Signal | Nov 2, 11:35 AM | 1 day ago |
| SMA: Bullish | Nov 2, 11:30 AM | 1 day ago |
| RSI: Oversold | Nov 2, 11:10 AM | 1 day ago |
| RSI: Oversold | Nov 2, 10:45 AM | 1 day ago |
| SMA: Bearish | Nov 2, 10:00 AM | 1 day ago |
| SMA: Bearish | Nov 2, 9:40 AM | 1 day ago |
| MACD: Sell Signal | Nov 2, 9:40 AM | 1 day ago |
| SMA: Bearish | Nov 2, 9:30 AM | 1 day ago |
Newest 20 of 105.
Analyst view
Price target (mean) 37.00 +150.3% upside
Now 14.79
- Target (low)
- 35.00
- Target (mean)
- 37.00
- Target (high)
- 39.00
Ratings (0m) 3 3 buy · 0 hold · 0 sell
- Strong buy2
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 3
- 2 months ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.08 | -0.08 – -0.08 | 0.00 | 0.0% | 54.86M | 0.0% | 1 |
| Next quarter | -0.07 | -0.07 – -0.07 | 0.00 | 0.0% | 57.24M | +33.4% | 1 |
| Current year | -0.055 | -0.12 – 0.01 | -0.444 | +87.6% | 254.41M | +51.6% | 2 |
| Next year | 0.455 | 0.36 – 0.55 | -0.055 | +927.3% | 415.69M | +63.4% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 27, 2026 | Piper Sandler | Reiterated | Overweight | Overweight |
| Nov 25, 2025 | Jefferies | Upgrade | Hold | Buy |
| Jul 18, 2025 | Jefferies | Downgrade | Buy | Hold |
| Feb 7, 2025 | Piper Sandler | Reiterated | Overweight | Overweight |
| Dec 23, 2024 | Jefferies | Downgrade | Buy | Hold |
| Dec 19, 2024 | Piper Sandler | Maintained | Overweight | Overweight |
| Jul 23, 2024 | Piper Sandler | Upgrade | Neutral | Overweight |
| Jun 20, 2024 | Cantor Fitzgerald | Reiterated | — | Overweight |
| Jun 4, 2024 | Cantor Fitzgerald | Reiterated | — | Overweight |